Showing results (1341-1350 of 5,535) with videos related to
Sort By:
Pageof 554
Inflammatory Bowel Diseases|April 13, 2026
Frailty in inflammatory bowel disease: a missing link in personalized care for the aging IBD populationGuillaume Le Cosquer, Cyrielle Gilletta, Bharati Kochar, et al.Inflammatory Bowel Diseases|April 13, 2026
Effect of polydeoxyribonucleotide as a potential therapeutic agent to enhance the healing of Crohn's perianal fistulaHyeon Kyeong Kim, Yong Sik Yoon, Jong Lyul Lee, et al.Inflammatory Bowel Diseases|April 12, 2026
Disentangling the gut microbiome and inflammation in inflammatory bowel diseases: longitudinal observations from the IBSEN III studyMaria G Maseng, Simen H Hansen, Olle Grännö, et al.Inflammatory Bowel Diseases|April 15, 2026
Ustekinumab resistance in individuals with ulcerative colitis is associated with an alteration of a subset of proinflammatory mucosal regulatory T cellsKristi C Briggs, Ada Tam, Lara Chaaban, et al.Inflammatory Bowel Diseases|August 12, 2026
Prior adalimumab exposure alters infliximab pharmacokinetics and trough targets in pediatric Crohn's diseaseYiyoung Kwon, Yoon Zi Kim, Tae Jong Jeong, et al.Inflammatory Bowel Diseases|August 19, 2026
Coccidioidomycosis in patients with inflammatory bowel disease receiving advanced therapy: An observational study from an endemic tertiary centerFares Jamal, Alejandro J Gonzalez, Geoff Thomas, et al.Inflammatory Bowel Diseases|August 18, 2026
Hormonal contraception is not associated with recurrent flares in ulcerative colitis: a longitudinal time-dependent analysisBeatriz Gros, Carlos Frutos, Eduard Brunet, et al.Inflammatory Bowel Diseases|August 18, 2026
Effectiveness, Durability, and Safety of Ustekinumab in Inflammatory Bowel Disease: Results from the Taiwan Multicenter Real-world Ustekinumab Study (T-RUST Study)Shih-Hua Lin, Chia-Jung Kuo, Chiao-Hsiung Chuang, et al.Inflammatory Bowel Diseases|August 7, 2026
Sarcopenia as a prognostic marker in inflammatory bowel disease: Implications for endoscopic outcomes and loss of response to biologic therapy-A systematic review with narrative synthesisThomas Fuchs, Vanessa StadlbauerInflammatory Bowel Diseases|August 21, 2026
GLP-1 receptor agonist therapy is associated with increased symptomatic remission in ulcerative colitis: a matched cohort studyBudoor Alqinai, Swapna Gayam, Jennifer Hadam-VeverkaPageof 554